Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label updates from v3.8.0 to v3.8.1, while the study record content remains unchanged.
    Difference
    0.0%
    Check dated 2026-11-18T01:43:29.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The record now presents details of AbbVie’s completed Phase 3 risankizumab maintenance study for moderate-to-severe plaque psoriasis, including eligibility, treatment and outcomes, locations, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-10T22:55:39.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now identifies the platform as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T22:58:46.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a website transition and a terminology change from “Artificial Intelligence” to “Super Intelligence.” The site revision changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:24:14.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-06T22:36:57.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record details, signaling restricted access to the content. Previous study content and related metadata are no longer visible.
    Difference
    17%
    Check dated 2026-09-22T23:16:38.000Z thumbnail image

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.